Shawn Malone

University of Ottawa, Ottawa Hospital

Papers

4

Total Citations

18

H-Index

2

About

Dr. Shawn Malone is a leading radiation oncologist whose research focuses on the application of advanced stereotactic ablative radiotherapy (SABR) and radiosurgery (SRS) techniques, particularly using the CyberKnife robotic platform. His major contributions lie in refining treatment for complex intracranial and extracranial tumors, demonstrating the feasibility and clinical utility of novel approaches. Notably, his 2015 study on platinum fiducial seeds for MRI/CT fusion and real-time tumor tracking during CyberKnife SABR (9 citations) established a critical methodology for treating moving targets with high precision. He has also advanced the management of benign brain tumors, as shown in his work on unresectable foramen magnum meningiomas (6 citations) and a mature analysis of 120 acoustic neuroma cases (2 citations), providing long-term outcome data. Additionally, his exploration of selective angiography for arteriovenous malformation radiosurgery planning (1 citation) highlights his commitment to optimizing treatment accuracy. Dr. Malone’s cumulative work, though with modest citation counts, has had a tangible impact on clinical practice, offering safer, non-invasive options for patients with challenging tumor locations and improving the integration of imaging and robotic delivery systems.

Research Focus

Key Achievements

2
H-Index
4
Papers
18
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility, detectability and clinical experience with platinum fiducial seeds for MRI/CT fusion and real-time tumor tracking during CyberKnife<sup>®</sup> stereotactic ablative radiotherapy.
9 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: University of Ottawa, Ottawa Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago